vs
Side-by-side financial comparison of RHYTHM PHARMACEUTICALS, INC. (RYTM) and Velocity Financial, Inc. (VEL). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $51.6M, roughly 1.1× Velocity Financial, Inc.). Velocity Financial, Inc. runs the higher net margin — 67.3% vs -83.0%, a 150.3% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 32.8%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 32.3%).
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
Velocity Financial, Inc. is a U.S.-headquartered real estate finance company that offers specialized mortgage loan solutions primarily for residential investment properties. It partners with independent mortgage brokers nationwide, providing real estate investors with short-term bridge loans and long-term rental property financing options tailored to their operational needs.
RYTM vs VEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.3M | $51.6M |
| Net Profit | $-47.5M | $34.8M |
| Gross Margin | 91.6% | — |
| Operating Margin | -82.2% | 97.0% |
| Net Margin | -83.0% | 67.3% |
| Revenue YoY | 36.9% | 32.8% |
| Net Profit YoY | -9.6% | 67.0% |
| EPS (diluted) | $-0.73 | $0.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $57.3M | $51.6M | ||
| Q3 25 | $51.3M | $49.1M | ||
| Q2 25 | $48.5M | $47.6M | ||
| Q1 25 | $32.7M | $37.5M | ||
| Q4 24 | $41.8M | $38.9M | ||
| Q3 24 | $33.3M | $35.1M | ||
| Q2 24 | $29.1M | $32.4M | ||
| Q1 24 | $26.0M | $29.5M |
| Q4 25 | $-47.5M | $34.8M | ||
| Q3 25 | $-52.9M | $25.4M | ||
| Q2 25 | $-46.6M | $26.0M | ||
| Q1 25 | $-49.5M | $18.9M | ||
| Q4 24 | $-43.3M | $20.8M | ||
| Q3 24 | $-43.6M | $15.8M | ||
| Q2 24 | $-32.3M | $14.8M | ||
| Q1 24 | $-141.4M | $17.3M |
| Q4 25 | 91.6% | — | ||
| Q3 25 | 89.3% | — | ||
| Q2 25 | 88.6% | — | ||
| Q1 25 | 88.8% | — | ||
| Q4 24 | 90.9% | — | ||
| Q3 24 | 88.5% | — | ||
| Q2 24 | 89.9% | — | ||
| Q1 24 | 89.2% | — |
| Q4 25 | -82.2% | 97.0% | ||
| Q3 25 | -102.6% | 72.1% | ||
| Q2 25 | -93.4% | 71.3% | ||
| Q1 25 | -143.7% | 71.7% | ||
| Q4 24 | -98.6% | 82.5% | ||
| Q3 24 | -132.0% | 60.6% | ||
| Q2 24 | -139.2% | 61.3% | ||
| Q1 24 | -538.7% | 78.8% |
| Q4 25 | -83.0% | 67.3% | ||
| Q3 25 | -103.1% | 51.7% | ||
| Q2 25 | -96.1% | 54.6% | ||
| Q1 25 | -151.4% | 50.4% | ||
| Q4 24 | -103.6% | 53.5% | ||
| Q3 24 | -131.2% | 45.1% | ||
| Q2 24 | -110.9% | 45.6% | ||
| Q1 24 | -544.4% | 58.5% |
| Q4 25 | $-0.73 | $0.90 | ||
| Q3 25 | $-0.82 | $0.65 | ||
| Q2 25 | $-0.75 | $0.69 | ||
| Q1 25 | $-0.81 | $0.51 | ||
| Q4 24 | $-0.71 | $0.56 | ||
| Q3 24 | $-0.73 | $0.44 | ||
| Q2 24 | $-0.55 | $0.42 | ||
| Q1 24 | $-2.35 | $0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $388.9M | $92.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $139.1M | $672.5M |
| Total Assets | $480.2M | $7.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $388.9M | $92.1M | ||
| Q3 25 | $416.1M | $99.0M | ||
| Q2 25 | $291.0M | $79.6M | ||
| Q1 25 | $314.5M | $51.7M | ||
| Q4 24 | $320.6M | $49.9M | ||
| Q3 24 | $298.4M | $44.1M | ||
| Q2 24 | $319.1M | $47.4M | ||
| Q1 24 | $201.2M | $34.8M |
| Q4 25 | $139.1M | $672.5M | ||
| Q3 25 | $148.8M | $634.3M | ||
| Q2 25 | $-11.9M | $597.9M | ||
| Q1 25 | $18.9M | $563.2M | ||
| Q4 24 | $21.7M | $516.9M | ||
| Q3 24 | $11.2M | $484.6M | ||
| Q2 24 | $39.3M | $471.3M | ||
| Q1 24 | $61.6M | $452.9M |
| Q4 25 | $480.2M | $7.4B | ||
| Q3 25 | $506.9M | $7.0B | ||
| Q2 25 | $372.7M | $6.5B | ||
| Q1 25 | $386.7M | $6.0B | ||
| Q4 24 | $392.3M | $5.5B | ||
| Q3 24 | $363.6M | $5.2B | ||
| Q2 24 | $381.8M | $4.9B | ||
| Q1 24 | $258.7M | $4.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.4M | $18.2M |
| Free Cash FlowOCF − Capex | — | $17.9M |
| FCF MarginFCF / Revenue | — | 34.6% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | 0.52× |
| TTM Free Cash FlowTrailing 4 quarters | — | $40.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.4M | $18.2M | ||
| Q3 25 | $-26.6M | $11.5M | ||
| Q2 25 | $-23.3M | $7.7M | ||
| Q1 25 | $-40.4M | $3.5M | ||
| Q4 24 | $-18.8M | $37.8M | ||
| Q3 24 | $-25.2M | $-17.6M | ||
| Q2 24 | $-29.1M | $11.5M | ||
| Q1 24 | $-40.7M | $10.6M |
| Q4 25 | — | $17.9M | ||
| Q3 25 | — | $11.4M | ||
| Q2 25 | — | $7.6M | ||
| Q1 25 | — | $3.5M | ||
| Q4 24 | — | $37.5M | ||
| Q3 24 | — | $-17.6M | ||
| Q2 24 | — | $11.4M | ||
| Q1 24 | — | $10.5M |
| Q4 25 | — | 34.6% | ||
| Q3 25 | — | 23.2% | ||
| Q2 25 | — | 15.9% | ||
| Q1 25 | — | 9.2% | ||
| Q4 24 | — | 96.4% | ||
| Q3 24 | — | -50.3% | ||
| Q2 24 | — | 35.1% | ||
| Q1 24 | — | 35.8% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | 0.52× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | — | 1.81× | ||
| Q3 24 | — | -1.11× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RYTM
Segment breakdown not available.
VEL
| Related Party | $19.3M | 37% |
| Nonrelated Party | $16.9M | 33% |
| Other | $15.4M | 30% |
